OrthoPediatrics director granted 11,436 shares

Infante (Reynolds) Marie C reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Infante (Reynolds) Marie C reported acquisition or exercise transactions in this Form 4 filing.

OrthoPediatrics Corp director Marie C. Infante received an equity grant of 11,436 shares of common stock on June 9, 2026. The shares were awarded at a price of $0.00 per share, indicating a compensation-related stock award rather than an open-market purchase.

Following this grant, Infante directly holds 31,202 shares of OrthoPediatrics common stock. A footnote explains that this total includes restricted stock awards totaling 17,959 shares, which are typically subject to vesting or service conditions.

Insider Trade Summary

Grant/Award: 11,436 shares

Grant/Award 1 txn

Insider Infante (Reynolds) Marie C

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	11,436	$0.00	$0.00

Holdings After Transaction: Common Stock — 31,202 shares (Direct)

Footnotes (1)

1. F1. Includes restricted stock awards totaling 17,959 shares.

Key Figures

Stock grant: 11,436 shares Grant price: $0.00 per share Total holdings after grant: 31,202 shares +1 more

4 metrics

Stock grant 11,436 shares Common stock grant to director on June 9, 2026

Grant price $0.00 per share Indicates compensation-related award, not market purchase

Total holdings after grant 31,202 shares Director’s direct OrthoPediatrics common stock holdings post-transaction

Restricted stock included 17,959 shares Portion of holdings identified as restricted stock awards

Key Terms

restricted stock awards, Common Stock, Grant, award, or other acquisition, Form 4

4 terms

restricted stock awards financial

"Includes restricted stock awards totaling 17,959 shares."

Restricted stock awards are company shares given to employees or executives that cannot be sold or transferred until certain conditions — like staying with the company for a set time or meeting performance targets — are met, like a gift that is locked in a safe until rules are satisfied. Investors care because these awards tie management’s pay to company performance, can increase the number of shares outstanding when they become tradable (dilution), and may signal expected future selling pressure or commitment to long-term growth.

Common Stock financial

"security_title: Common Stock"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

Grant, award, or other acquisition financial

"transaction_code_description: Grant, award, or other acquisition"

Form 4 regulatory

"INSIDER FILING DATA (Form 4):"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did OrthoPediatrics (KIDS) director Marie C. Infante report in this Form 4?

Marie C. Infante reported receiving a grant of 11,436 OrthoPediatrics common shares as compensation. The award was at $0.00 per share, meaning it was not a market purchase but a stock-based grant that increases her direct equity stake in the company.

How many OrthoPediatrics (KIDS) shares does Marie C. Infante hold after the grant?

After the reported grant, Marie C. Infante directly holds 31,202 OrthoPediatrics common shares. This total includes previously awarded restricted stock. The filing indicates that 17,959 of these shares are restricted stock awards, which typically vest over time or upon meeting conditions.

Was the OrthoPediatrics (KIDS) Form 4 transaction a stock purchase or a grant?

The Form 4 transaction is a stock grant, not an open-market purchase. The filing labels the code as “A” for grant or award and shows a price of $0.00 per share, reflecting compensation rather than a cash-funded acquisition in the public market.

What does the restricted stock footnote mean in the OrthoPediatrics (KIDS) Form 4?

The footnote explains that Infante’s holdings include restricted stock awards totaling 17,959 shares. Restricted stock typically has vesting or service requirements before it becomes fully transferable, aligning director compensation with longer-term company performance and continued service.

Does the OrthoPediatrics (KIDS) Form 4 show any insider stock sales?

The Form 4 does not report any stock sales by Marie C. Infante. It only shows an acquisition coded as a grant or award of 11,436 common shares, increasing her reported direct holdings without any corresponding disposition transaction.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/10/2026 - 09:49 AM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Infante (Reynolds) Marie C

(Last) (First) (Middle)

C/O ORTHOPEDIATRICS CORP.

2850 FRONTIER DRIVE

(Street)

WARSAW INDIANA 46582

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
ORTHOPEDIATRICS CORP [ KIDS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/09/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/09/2026		A		11,436	A	$0	31,202(1)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Includes restricted stock awards totaling 17,959 shares.

Remarks:

	/s/ Daniel J. Gerritzen, Attorney-in-Fact	06/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)